胡 祐寧

Medicine & Life Sciences

1. Extracorporeal Membrane Oxygenation 100%
2. Dissecting Aneurysm 86%
3. Mitral Valve 38%
4. Vaccination 30%
5. Perfusion 29%
6. SARS Virus 28%
7. Brachiocephalic Trunk 27%
8. Endocarditis 25%
9. Nanofibers 25%
10. Everolimus 24%
11. Coronavirus 24%
12. Aortic Coarctation 24%
13. Calcineurin Inhibitors 23%
14. Lymphoproliferative Disorders 22%
15. Cardiogenic Shock 22%
16. Transplant Recipients 22%
17. False Aneurysm 22%
18. Myocarditis 21%
19. Cardiopulmonary Bypass 21%
20. Surgeons 20%
21. Embolism 19%
22. Pulmonary Artery 19%
23. Cytomegalovirus 19%
24. Pulmonary Hypertension 19%
25. Vaccines 16%
26. Aorta 16%
27. Hospital Mortality 16%
28. Vascular Endothelial Growth Factor A 16%
29. Dialysis 16%
30. Virus Diseases 16%
31. Heart 15%
32. Cohort Studies 15%
33. Cognition 15%
34. Mortality 14%
35. Temperature 13%
36. Oxygen 13%
37. Survival 13%
38. Transplants 13%
39. Safety 12%
40. Prospective Studies 12%
41. Hydroxymethylglutaryl-CoA Reductase Inhibitors 11%